Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Dance Marathon vigil, hosted by the Pediatric AIDS Coalition at UCLA, worked to empower a new generation by breaking stigmas ...

Elon Musk claims he mistakenly fired Ebola prevention workers, then quickly fixed the error. But Ebola programs are still in ...

Yet, harmful myths about HIV persist ... and stigma that often prevent people from seeking care. The truth: HIV and AIDS are not the same. HIV (human immunodeficiency virus) is a virus that ...

Descovy is a brand-name oral tablet prescribed for HIV and to decrease the risk of contracting HIV. Descovy has boxed warnings. A boxed warning is the most serious warning from the Food and Drug ...

Antiretroviral drugs are used to treat HIV infection. They work by blocking a stage of the virus's life cycle and, by doing so, prevent the virus from replicating. The drugs are organized into six ...